Cidara Therapeutics Inc (NASDAQ: CDTX) Stock: Can It Surge Further?

In the last trading session, 1.87 million shares of the Cidara Therapeutics Inc (NASDAQ:CDTX) were traded, and its beta was 1.14. Most recently the company’s share price was $0.51, and it changed around $0.0 or -0.27% from the last close, which brings the market valuation of the company to $46.44M. CDTX currently trades at a discount to its 52-week high of $1.48, offering almost -190.2% off that amount. The share price’s 52-week low was $0.50, which indicates that the current value has risen by an impressive 1.96% since then. We note from Cidara Therapeutics Inc’s average daily trading volume that its 3-month average coming to 752.44K.

Cidara Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 1 recommended CDTX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.

Cidara Therapeutics Inc (NASDAQ:CDTX) trade information

Instantly CDTX has showed a red trend with a performance of -0.27% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -35.45% year-to-date, but still down -29.79% over the last five days. On the other hand, Cidara Therapeutics Inc (NASDAQ:CDTX) is -34.07% down in the 30-day period.

Cidara Therapeutics Inc (CDTX) estimates and forecasts

Cidara Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -40.13 percent over the past six months and at a -150.00% annual growth rate that is well below the industry average of 13.00%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 33.09%.